Concepedia

Yoshitaka Inaba

YI

Statistics

Publications

108

Citations

4.6K

H-Index

36

Active since

1982

Affiliations

Aichi Cancer Center(Current)

Shizuoka Cancer Center

National Cancer Center Hospital East

Nara Medical University

Kindai University

Yoshitaka Inaba is an author at Aichi Cancer Center specializing in medicine, oncology, and radiology.

ORCID

Top concepts

Publications per year

1982–2025

108

Publications

108

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

, , +10

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 254 citations · Full text

REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset

Tatsuya Yamashita, Masatoshi Kudo, Kenji Ikeda et al. · Journal of Gastroenterology · 2019 · 217 citations · Full text

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial

M. Ikeda, Satoshi Shimizu, Tosiya Sato et al. · Annals of Oncology · 2016 · 165 citations · Full text

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri et al. · The Lancet · 2025 · 151 citations · Full text

, , +8

1–5 of 108